From delayed reactive medical services to evidence-based Predictive, Preventive & Personalised Medicine.
About the EPMA Journal, IF 3.9
The main objective of the EPMA is to promote the paradigm change from delayed reactive medical services to evidence-based Predictive, Preventive & Personalised Medicine (PPPM) as an integrated science and healthcare practice.
The EPMA Journal is the main instrument for the PPPM promotion
EPMA Journal is a journal of predictive, preventive and personalised medicine (PPPM):
As the official journal of the EPMA, it has created an international forum for the discussion and exchange of research and methods to facilitate the creation of new approaches and models in PPPM, with a focus on the benefits to patients while advancing healthcare as a whole.
EPMA Journal occupies a unique niche in the scientific literature: the absolute majority of the articles (above 90%) currently indexed in PubMed and covering PPPM was published in EPMA Journal. To support the multidisciplinary concepts within PPPM, the EPMA Journal Editorial Board consists of researchers across a variety of fields, who are committed to the promotion of PPPM globally. Though many are based in the European Union, the geographical spread of the Editorial Board is global, with representatives in Switzerland, the United States of America, Canada, Australia, Japan, Israel, China, South Korea, Turkey, Russia, Ukraine and many other countries. There are several EBMs who are particularly prominent/highly cited. Even with predominantly European governance, the impact of the EPMA Journal has a global reach.
EPMA Journal was highlighted at the International EPMA Summit, carried out in the European Parliament in September 2013, as the publishing platform for innovative, evidence-based concepts for advancing healthcare in Europe and worldwide. Many relevant consortia and societies refer to the recommendations and guidelines published in the EPMA Journal.
In 2016, Scopus has placed EPMA Journal amongst the top journals in the area "Health Policy": link.
Scopus, Scimago and Google Scholar demostrate ever increasing citation rates for the articles published in EPMA Journal, including the research articles (e.g. "Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine" with sufficiently over 100 citations), the review articles (e.g. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments' with sufficiently over 100 citations) and position papers (e.g. "General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper for European Association of Predictive, Preventive and Personalised Medicine" with over 90 citations) (Google Scholar, March 2017): link.
The journal provides the contributors with the "hybrid publishing model" which means that the authors may freely decide between publishing without the fee by "subscription" or, alternatively, paying the publishing fee for utilising the "open access" option - both indexed in "PubMed". This is currenlty the best model offered by the publishing houses worldwide.
For the electronic submission please use the following link:
Please convey our message to your organisations and professional networks!